Wold W S, Gooding L R
Institute for Molecular Virology, St Louis University School of Medicine, MO 63110.
Mol Biol Med. 1989 Oct;6(5):433-52.
Human adenoviruses are providing insights into strategies that viruses may adopt to evade immune surveillance. There are 47 serotypes that form six groups (A to F) with different genetic and biological properties. Adenovirus type 2 (Ad2) and Ad5, two group C types, the most common and best understood in terms of molecular biology, cause respiratory infections in young children and often form persistent infections. Following infection, the linear duplex DNA genome is expressed in two broad phases: "early", when viral proteins function to usurp the cell; and "late", when viral DNA and structural proteins are synthesized and virions are assembled. One of the early transcription units, region E3, encodes two proteins that appear to counteract different branches of the host's anti-viral defenses. A 19,000 Mr protein called gp19K protects cells against cytolysis by adenovirus-specific cytotoxic T lymphocytes (CTL). Gp19K has two properties that are crucial to this function: it is localized in the endoplasmic reticulum, and it binds strongly to class I antigens of the major histocompatibility complex (MHC). The effect of these two properties is to block transport of class I antigens to the cell surface. In order to lyse adenovirus-infected cells, CTL must recognize adenovirus peptide antigens complexed with class I major histocompatability complex antigens displayed on the cell surface. Since gp19K prevents this, it renders the cell effectively invisible to CTL. The second anti-immune E3 protein is a 14,700 Mr protein called 14.7K. The 14.7K protects adenovirus-infected cells against cytolysis by tumor necrosis factor (TNF). TNF is a pleiotropic immunoregulatory protein that has anti-viral properties and is believed to provide a defense against virus infections. The 14.7K presumably counteracts the anti-viral effects of TNF in vivo. The mechanism of action of the 14.7K is unknown. Further studies on gp19K and 14.7K should assist our understanding of the immune system and adenovirus pathogenesis.
人类腺病毒正在为病毒可能采用的逃避免疫监视的策略提供见解。有47种血清型,它们形成六个组(A至F),具有不同的遗传和生物学特性。2型腺病毒(Ad2)和5型腺病毒(Ad5)属于C组,是分子生物学中最常见且了解最多的两种,可引起幼儿呼吸道感染,并常形成持续性感染。感染后,线性双链DNA基因组在两个主要阶段表达:“早期”,此时病毒蛋白发挥作用篡夺细胞;“晚期”,此时合成病毒DNA和结构蛋白并组装病毒粒子。早期转录单位之一E3区编码两种蛋白,这两种蛋白似乎能对抗宿主抗病毒防御的不同分支。一种名为gp19K的19000道尔顿蛋白可保护细胞免受腺病毒特异性细胞毒性T淋巴细胞(CTL)的细胞溶解作用。Gp19K具有对该功能至关重要的两个特性:它定位于内质网,并且与主要组织相容性复合体(MHC)的I类抗原强烈结合。这两个特性的作用是阻止I类抗原转运到细胞表面。为了裂解腺病毒感染的细胞,CTL必须识别与细胞表面展示的I类主要组织相容性复合体抗原复合的腺病毒肽抗原。由于gp19K阻止了这一过程,它使细胞对CTL实际上不可见。第二种抗免疫E3蛋白是一种名为14.7K的14700道尔顿蛋白。14.7K可保护腺病毒感染的细胞免受肿瘤坏死因子(TNF)的细胞溶解作用。TNF是一种具有多效性的免疫调节蛋白,具有抗病毒特性,被认为可提供针对病毒感染的防御。14.7K可能在体内抵消TNF的抗病毒作用。14.7K的作用机制尚不清楚。对gp19K和14.7K的进一步研究应有助于我们对免疫系统和腺病毒发病机制的理解。